Table 5 Five year relative survival of patients diagnosed with CML in Germany and the US for (a) men and (b) women, 2002–06
| Â | Germany | US | ||||||
|---|---|---|---|---|---|---|---|---|
Age | N | RS | SE | N | RS | SE | Diff | P (Model) |
      a. Men | ||||||||
15-39 | 207 | 78.4 | 4.1 | 528 | 80.6 | 2.6 | −2.2 | 0.5275 |
40-49 | 184 | 76.5 | 4.5 | 383 | 80.5 | 3.1 | −4 | 0.3275 |
50-59 | 234 | 65.1 | 5.1 | 401 | 73.9 | 3.5 | −8.8 | 0.0575 |
60-64 | 207 | 61.5 | 5.6 | 191 | 68.8 | 5.5 | −7.3 | 0.3367 |
65-69 | 242 | 50.3 | 5.5 | 204 | 48.9 | 5.7 | +1.4 | 0.6480 |
Overall | 1074 | 65.5 | 2.3 | 1707 | 69.7a | 2.0 | −4.2 | 0.0273 |
     b. Women | ||||||||
15-39 | 117 | 91.2 | 4.0 | 290 | 84.4 | 3.1 | +6.8 | 0.2632 |
40-49 | 144 | 80.1 | 5.0 | 297 | 85.8 | 3.1 | −5.7 | 0.3460 |
50-59 | 189 | 69.6 | 4.8 | 296 | 84.0 | 3.6 | −14.6 | 0.0050 |
60-64 | 154 | 69.1 | 5.3 | 149 | 71.7 | 6.1 | −2.6 | 0.4252 |
65-69 | 170 | 59.2 | 5.5 | 171 | 61.4 | 6.1 | −2.2 | 0.6316 |
Overall | 774 | 72.8 | 2.3 | 1203 | 77.0a | 2.1 | −4.2 | 0.0453 |